Gossamer Bio (GOSS) FCF Margin (2022 - 2025)
Historic FCF Margin for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 272.06%.
- Gossamer Bio's FCF Margin rose 658500.0% to 272.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 790.58%, marking a year-over-year decrease of 7892400.0%. This contributed to the annual value of 3.82% for FY2024, which is N/A changed from last year.
- Per Gossamer Bio's latest filing, its FCF Margin stood at 272.06% for Q3 2025, which was up 658500.0% from 410.08% recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's FCF Margin ranged from a high of 1547.16% in Q1 2022 and a low of 410.08% during Q2 2025
- In the last 4 years, Gossamer Bio's FCF Margin had a median value of 242.65% in 2024 and averaged 532.58%.
- Over the last 5 years, Gossamer Bio's FCF Margin had its largest YoY gain of 658500bps in 2025, and its largest YoY loss of -5314700bps in 2025.
- Quarter analysis of 4 years shows Gossamer Bio's FCF Margin stood at 1383.63% in 2022, then grew by 9bps to 1513.97% in 2023, then tumbled by -84bps to 242.65% in 2024, then tumbled by -212bps to 272.06% in 2025.
- Its FCF Margin stands at 272.06% for Q3 2025, versus 410.08% for Q2 2025 and 401.96% for Q1 2025.